Drug Type Small molecule drug |
Synonyms Ephedirne Hydrichloride and Nitrofurazone Nasal Drops, Ephednne Hydrochloride Nasal Drops, Ephedrine Hyarochloride and Dipnenhydramine Hydrochloride + [22] |
Target |
Action agonists |
Mechanism adrenergic receptor agonists(Adrenergic receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Australia (03 Mar 2017), |
Regulation- |
Molecular FormulaC10H16ClNO |
InChIKeyBALXUFOVQVENIU-GNAZCLTHSA-N |
CAS Registry50-98-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypotension | Australia | 03 Mar 2017 | |
Asthma | - | - | - |
Nasal Obstruction | - | - | - |
Pulmonary Disease, Chronic Obstructive | - | - | - |
Phase 4 | 28 | kiuovcuyby(fpkyuulhxm) = pellkbgetp czltxlstbk (mekqmdeygq ) | - | 01 Apr 2020 | |||
Phase 2 | 53 | Saline Placebo (Saline Placebo) | mncywvvxfw(bfhavirghc) = ftbupewmne bxfotoplmy (horizjanle, 0.26) View more | - | 22 May 2017 | ||
(IM Ephedrine) | mncywvvxfw(bfhavirghc) = kdofolwlfe bxfotoplmy (horizjanle, 0) View more | ||||||
Not Applicable | 90 | Caffeine/Ephedrine (CE) | eczmfplcop(hrcmcykuof) = velbxocdfc xmpmffmcfy (wftpjrihkj ) View more | - | 01 Oct 2013 | ||
Leptin A-200 and Caffeine/Ephedrine (LCE) | grqxxnsfkh(foaozvjfqv) = qvjcbqjdol nwwgbjfstr (bpstraoomt ) View more |